V026-9329 Screening compound: N-[3-({1-cyclohexyl[(3-fluorophenyl)carbamoyl]amino}methyl)-4-[methyl(1-methylpiperidin-4-yl)amino]phenyl]cyclopropanecarboxamide

V026-9329 Screening compound: N-[3-({1-cyclohexyl[(3-fluorophenyl)carbamoyl]amino}methyl)-4-[methyl(1-methylpiperidin-4-yl)amino]phenyl]cyclopropanecarboxamide
V026-9329 Screening compound: N-[3-({1-cyclohexyl[(3-fluorophenyl)carbamoyl]amino}methyl)-4-[methyl(1-methylpiperidin-4-yl)amino]phenyl]cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V026-9329
N-[3-({1-cyclohexyl[(3-fluorophenyl)carbamoyl]amino}methyl)-4-[methyl(1-methylpiperidin-4-yl)amino]phenyl]cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V026-9329

Molecular Formula

C31H42FN5O2 (C31 H42 FN5 O2)

Compound Name

N-[3-({1-cyclohexyl[(3-fluorophenyl)carbamoyl]amino}methyl)-4-[methyl(1-methylpiperidin-4-yl)amino]phenyl]cyclopropanecarboxamide

IUPAC name

N-[3-({1-cyclohexyl[(3-fluorophenyl)carbamoyl]amino}methyl)-4-[methyl(1-methylpiperidin-4-yl)amino]phenyl]cyclopropanecarboxamide

SMILES

CN(C1CCN(C)CC1)c(cc1)c(CN(C2CCCCC2)C(Nc2cccc(F)c2)=O)cc1NC(C1CC1)=O

InChI

InChI=1S/C31H42FN5O2/c1-35-17-15-27(16-18-35)36(2)29-14-13-26(33-30(38)22-11-12-22)19-23(29)21-37(28-9-4-3-5-10-28)31(39)34-25-8-6-7-24(32)20-25/h6-8,13-14,19-20,22,27-28H,3-5,9-12,15-18,21H2,1-2H3,(H,33,38)(H,34,39)

InChI Key

NXVVSIBYOJRWLA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19801075

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

535.71

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.290

Distribution Coefficient, logD

4.264

Water Solubility, LogSw

-5.22

Polar Surface Area

53.040

Acid Dissociation Constant (pKa)

12.46

Base Dissociation Constant (pKb)

8.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.80

V026-9329 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Lipid Metabolism Library (9174 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with V026-9329 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V026-9329?
Check Price and Availability of V026-9329, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V026-9329 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V026-9329
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V026-9329
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V026-9329 available by request